The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts
- 24 April 1995
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 277 (2-3) , 271-274
- https://doi.org/10.1016/0014-2999(95)00111-w
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.Circulation, 1994
- Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism.Circulation Research, 1993
- The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts.Circulation, 1993
- Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channelsCardiovascular Research, 1993
- Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamideCardiovascular Research, 1993
- Adenosine and the anti-infarct effects of preconditioningCardiovascular Research, 1993
- Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoateCardiovascular Research, 1992
- Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.Circulation Research, 1991
- Hypoxic Dilation of Coronary Arteries Is Mediated by ATP-Sensitive Potassium ChannelsScience, 1990
- Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heartJournal of Molecular and Cellular Cardiology, 1990